X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39408) 39408
Patent (14110) 14110
Newspaper Article (605) 605
Magazine Article (316) 316
Newsletter (269) 269
Book Chapter (165) 165
Book / eBook (115) 115
Dissertation (28) 28
Trade Publication Article (23) 23
Government Document (21) 21
Conference Proceeding (18) 18
Reference (9) 9
Web Resource (9) 9
Book Review (8) 8
Publication (6) 6
Streaming Video (3) 3
Journal / eJournal (1) 1
Report (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30476) 30476
steroids (29071) 29071
female (17713) 17713
male (17241) 17241
chemistry (14504) 14504
organic chemistry (14384) 14384
metallurgy (14113) 14113
hygiene (13881) 13881
human necessities (13874) 13874
medical or veterinary science (13872) 13872
preparations for medical, dental, or toilet purposes (13634) 13634
specific therapeutic activity of chemical compounds ormedicinal preparations (13519) 13519
adult (10275) 10275
middle aged (9285) 9285
steroids - therapeutic use (7906) 7906
animals (6980) 6980
aged (5809) 5809
treatment outcome (5593) 5593
corticosteroids (5484) 5484
adolescent (4481) 4481
child (4131) 4131
pharmacology & pharmacy (3655) 3655
anti-inflammatory agents - therapeutic use (3373) 3373
analysis (3074) 3074
therapy (2998) 2998
care and treatment (2992) 2992
steroid hormones (2897) 2897
surgery (2731) 2731
glucocorticoids - therapeutic use (2699) 2699
retrospective studies (2693) 2693
immunosuppressive agents - therapeutic use (2462) 2462
risk factors (2446) 2446
medicine & public health (2420) 2420
health aspects (2410) 2410
child, preschool (2400) 2400
research (2384) 2384
pediatrics (2325) 2325
endocrinology & metabolism (2255) 2255
children (2240) 2240
rats (2169) 2169
neurosciences (2145) 2145
immunology (2124) 2124
time factors (2093) 2093
medicine, general & internal (2046) 2046
patients (1994) 1994
young adult (1986) 1986
oncology (1984) 1984
drug therapy (1963) 1963
mice (1948) 1948
dexamethasone (1936) 1936
follow-up studies (1935) 1935
inflammation (1922) 1922
drug therapy, combination (1865) 1865
clinical neurology (1785) 1785
adrenal cortex hormones - therapeutic use (1769) 1769
prospective studies (1739) 1739
asthma (1729) 1729
heterocyclic compounds (1696) 1696
transplantation (1642) 1642
diagnosis (1639) 1639
prognosis (1638) 1638
infant (1616) 1616
aged, 80 and over (1595) 1595
glucocorticoids (1591) 1591
expression (1558) 1558
cancer (1556) 1556
disease (1550) 1550
testosterone (1526) 1526
management (1490) 1490
pregnancy (1483) 1483
hormones (1482) 1482
double-blind (1452) 1452
dose-response relationship, drug (1428) 1428
medicine (1421) 1421
asthma - drug therapy (1416) 1416
urology & nephrology (1409) 1409
specific use of cosmetics or similar toiletpreparations (1327) 1327
physiological aspects (1316) 1316
studies (1278) 1278
steroids - administration & dosage (1271) 1271
double-blind method (1267) 1267
abridged index medicus (1265) 1265
gastroenterology & hepatology (1256) 1256
estrogen (1254) 1254
biopsy (1240) 1240
clinical trials (1203) 1203
medical research (1189) 1189
glucocorticoids - administration & dosage (1176) 1176
gene expression (1162) 1162
research article (1159) 1159
proteins (1158) 1158
efficacy (1140) 1140
recurrence (1134) 1134
metabolism (1132) 1132
steroid (1132) 1132
rheumatology (1110) 1110
dosage and administration (1104) 1104
prednisolone - therapeutic use (1097) 1097
biochemistry & molecular biology (1093) 1093
gonadal steroid hormones - therapeutic use (1087) 1087
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (78) 78
UofT at Mississauga - Stacks (11) 11
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
UofT at Scarborough - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
New College (Ivey) - Stacks (2) 2
OISE - Stacks (2) 2
Sunnybrook Health Sciences Centre - Holland Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Online (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (50216) 50216
French (4426) 4426
German (3050) 3050
Chinese (1278) 1278
Spanish (950) 950
Japanese (748) 748
Portuguese (429) 429
Russian (395) 395
Korean (358) 358
Danish (261) 261
Polish (223) 223
Norwegian (196) 196
Italian (180) 180
Hungarian (152) 152
Czech (128) 128
Finnish (126) 126
Swedish (98) 98
Hebrew (74) 74
Slovenian (74) 74
Dutch (63) 63
Slovak (55) 55
Turkish (44) 44
Bulgarian (43) 43
Serbian (43) 43
Croatian (36) 36
Icelandic (32) 32
Greek (31) 31
Estonian (24) 24
Ukrainian (22) 22
Lithuanian (19) 19
Romanian (15) 15
Indonesian (12) 12
Arabic (11) 11
Latvian (7) 7
Afrikaans (4) 4
Bosnian (2) 2
Armenian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 8, p. CD001955
Background Glucocorticoids are commonly used for croup in children. This is an update of a Cochrane Review published in 1999 and previously updated in 2004 and... 
Epinephrine | Croup/epiglottitis | Budesonide | Dexamethasone | Lungs & airways | Glucocorticoids | Respiratory infections: croup/epiglottitis | Fluticasone | Randomized Controlled Trials as Topic | Ear, nose, & throat | Infectious disease | Beclomethasone | Treatment | Child health | Respiratory infections | Larynx | Betamethasone | Medicine General & Introductory Medical Sciences | Croup | Prednisolone | Ear, nose & throat | Steroids | Epinephrine [therapeutic use] | Severity of Illness Index | NEBULIZED RACEMIC EPINEPHRINE | STEROID TREATMENT | INTRAMUSCULAR DEXAMETHASONE | Budesonide [therapeutic use] | Croup [drug therapy] | Dexamethasone [therapeutic use] | Humans | RANDOMIZED DOUBLE-BLIND | VIRAL CROUP | Androstadienes [therapeutic use] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [therapeutic use] | EMERGENCY-DEPARTMENTS | Time Factors | Prednisolone [therapeutic use] | OUTPATIENT TREATMENT | TREATING CROUP | PLACEBO-CONTROLLED TRIAL | ORAL DEXAMETHASONE | Child | Glucocorticoids - therapeutic use | Croup - drug therapy | Child, Preschool | Infant | Fluticasone - therapeutic use | Dexamethasone - therapeutic use | Epinephrine - therapeutic use | Budesonide - therapeutic use | Adolescent | Prednisolone - therapeutic use | Betamethasone - therapeutic use | Beclomethasone - therapeutic use | Infant, Newborn
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198184
... of splenectomy (Splx) as the first and still successfully used therapeutic measure in management of immune thrombocytopenia (ITP) [1]. The second therapeutic measure... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
Cochrane library, ISSN 1465-1858, 2014, Volume 2014, Issue 11, p. CD010699
Background Most people who receive a kidney transplant die from either cardiovascular disease or cancer before their transplant fails. The most common reason... 
Immunosuppressive Agents | Sirolimus | Lymphoproliferative Disorders | Induction therapy/primary immunosuppression | Cyclosporine | Recombinant Fusion Proteins | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Abatacept | Kidney transplant | Child health | TRANSPLANTATION: KIDNEY | Induction therapy / primary immunosuppression | Antibody therapy | Kidney disease | Acute rejection | Graft Survival | Kidney Transplantation | Prednisone | Alemtuzumab | Antibodies, Monoclonal | Mycophenolic Acid | Randomized Controlled Trials as Topic | Immunoconjugates | Tacrolimus | Basiliximab | Graft Rejection | Antilymphocyte Serum | Medicine General & Introductory Medical Sciences | LONG-TERM EXTENSION | MEDICINE, GENERAL & INTERNAL | STEROID-AVOIDING REGIMENS | MAINTAINING RENAL-FUNCTION | RANDOMIZED-TRIALS BENEFIT | EXT COMPARING BELATACEPT | COMPOSITE PATIENT/GRAFT SURVIVAL | EBV PLUS RECIPIENTS | CYCLOSPORINE-BASED IMMUNOSUPPRESSION | PATIENTS RECEIVING BELATACEPT | DONOR-SPECIFIC ANTIBODIES | Humans | Immunosuppressive Agents - therapeutic use | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Graft Rejection - mortality | Antilymphocyte Serum - therapeutic use | Immunoconjugates - therapeutic use | Lymphoproliferative Disorders - etiology | Immunoconjugates - adverse effects | Sirolimus - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Graft Rejection - prevention & control | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Calcineurin Inhibitors - therapeutic use | Immunosuppressive Agents - adverse effects | Kidney Transplantation - mortality | Prednisone - therapeutic use
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 4, p. CD006545
Background Infantile haemangiomas (previously known as strawberry birthmarks) are soft, raised swellings of the skin that occur in 3% to 10% of infants. These... 
Vascular birthmarks e.g infantile haemangiomas | Adrenal Cortex Hormones | Methylprednisolone | Photochemotherapy | topical steroids | lasers | Bleomycin | corticosteroids | Child health | systemic steroids | Propranolol | Hemangioma, Capillary | Prednisolone | Timolol | W. BIRTH MARKS AND DEVELOPMENTAL ABNORMALITIES OF THE SKIN | vincristine | Antineoplastic Agents | Radiotherapy | interferon | Remission Induction | Skin disorders | laser therapy | Randomized Controlled Trials as Topic | intralesional steroids | Skin Neoplasms | imiquimod | Adrenergic beta‐Antagonists | Lasers, Dye | Birthmarks | Skin | Medicine General & Introductory Medical Sciences | W6 Vascular malformations e.g. port‐wine stains | surgery | Antineoplastic Agents [therapeutic use] | Humans | Prednisolone [adverse effects; therapeutic use] | Child, Preschool | Infant | RANDOMIZED CONTROLLED-TRIAL | INTRALESIONAL BLEOMYCIN | MEDICINE, GENERAL & INTERNAL | PULSED DYE-LASER | Radiotherapy [methods] | TOPICAL PROPRANOLOL | Bleomycin [therapeutic use] | INTENSITY FOCUSED ULTRASOUND | TIMOLOL MALEATE 0.5-PERCENT | UNTREATED HEMANGIOMAS | SEQUENTIAL COMBINATION | RISK-FACTORS | Lasers, Dye [therapeutic use] | Remission Induction [methods] | Skin Neoplasms [therapy] | Adrenal Cortex Hormones [adverse effects; therapeutic use] | ORAL PROPRANOLOL | Hemangioma, Capillary [therapy] | Methylprednisolone [adverse effects; therapeutic use] | Photochemotherapy [methods] | Prednisolone - adverse effects | Methylprednisolone - therapeutic use | Skin Neoplasms - therapy | Hemangioma, Capillary - therapy | Photochemotherapy - methods | Timolol - administration & dosage | Methylprednisolone - adverse effects | Antineoplastic Agents - therapeutic use | Lasers, Dye - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Bleomycin - therapeutic use | Propranolol - administration & dosage | Radiotherapy - methods | Remission Induction - methods | Prednisolone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 6, p. CD003725
...), and strength at two years (two‐year data on function are very limited). Corticosteroids, now part of care recommendations for DMD, are largely in routine use, although... 
Muscle Diseases | Pregnenediones | Glucocorticoids | Adrenal Cortex Hormones | Prednisone | Randomized Controlled Trials as Topic | Walking | Neurology | Duchenne muscular dystrophy | Child health | Quality of Life | Muscular dystrophies | Muscle disease | Muscular Dystrophy, Duchenne | Medicine General & Introductory Medical Sciences | Muscle Strength | Prednisolone | Corticosteroid treatment | AMERICAN ACADEMY | CONTROLLED-TRIAL | LOW-DOSAGE | Humans | Male | Adrenal Cortex Hormones [adverse effects; therapeutic use] | MEDICINE, GENERAL & INTERNAL | Glucocorticoids [adverse effects; therapeutic use] | PREDNISONE TREATMENT | Prednisolone [therapeutic use] | Prednisone [therapeutic use] | DEFLAZACORT TREATMENT | GLYCOPROTEIN COMPLEX | DOUBLE-BLIND | Muscular Dystrophy, Duchenne [drug therapy] | MOLECULAR PATHOGENESIS | Pregnenediones [therapeutic use] | STEROID-THERAPY | LONG-TERM TREATMENT | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Muscular Dystrophy, Duchenne - drug therapy | Pregnenediones - administration & dosage | Adrenal Cortex Hormones - therapeutic use | Pregnenediones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Muscle Strength - drug effects | Prednisolone - therapeutic use | Glucocorticoids - adverse effects | Prednisone - therapeutic use | Adrenal Cortex Hormones - administration & dosage
Journal Article